Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.
van der Veer A, Waanders E, Pieters R, Willemse ME, Van Reijmersdal SV, Russell LJ, Harrison CJ, Evans WE, van der Velden VH, Hoogerbrugge PM, Van Leeuwen F, Escherich G, Horstmann MA, Mohammadi Khankahdani L, Rizopoulos D, De Groot-Kruseman HA, Sonneveld E, Kuiper RP, Den Boer ML. van der Veer A, et al. Among authors: van reijmersdal sv, van der velden vh, van leeuwen f. Blood. 2013 Oct 10;122(15):2622-9. doi: 10.1182/blood-2012-10-462358. Epub 2013 Aug 23. Blood. 2013. PMID: 23974192 Free PMC article.
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
Buitenkamp TD, Pieters R, Gallimore NE, van der Veer A, Meijerink JP, Beverloo HB, Zimmermann M, de Haas V, Richards SM, Vora AJ, Mitchell CD, Russell LJ, Schwab C, Harrison CJ, Moorman AV, van den Heuvel-Eibrink MM, den Boer ML, Zwaan CM. Buitenkamp TD, et al. Among authors: van den heuvel eibrink mm, van der veer a. Leukemia. 2012 Oct;26(10):2204-11. doi: 10.1038/leu.2012.84. Epub 2012 Mar 22. Leukemia. 2012. PMID: 22441210
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
van der Veer A, Zaliova M, Mottadelli F, De Lorenzo P, Te Kronnie G, Harrison CJ, Cavé H, Trka J, Saha V, Schrappe M, Pieters R, Biondi A, Valsecchi MG, Stanulla M, den Boer ML, Cazzaniga G. van der Veer A, et al. Blood. 2014 Mar 13;123(11):1691-8. doi: 10.1182/blood-2013-06-509794. Epub 2013 Dec 23. Blood. 2014. PMID: 24366361 Free article.
Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia.
van der Veer A, van der Velden VH, Willemse ME, Hoogeveen PG, Petricoin EF, Beverloo HB, Escherich G, Horstmann MA, Pieters R, den Boer ML. van der Veer A, et al. Among authors: van der velden vh. Blood Cancer J. 2014 Feb 14;4(2):e181. doi: 10.1038/bcj.2014.5. Blood Cancer J. 2014. PMID: 24531445 Free PMC article. No abstract available.
Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
van den Berk LC, van der Veer A, Willemse ME, Theeuwes MJ, Luijendijk MW, Tong WH, van der Sluis IM, Pieters R, den Boer ML. van den Berk LC, et al. Among authors: van der sluis im, van der veer a. Br J Haematol. 2014 Jul;166(2):240-9. doi: 10.1111/bjh.12883. Epub 2014 Apr 4. Br J Haematol. 2014. PMID: 24697337 Free article.
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.
Boer JM, van der Veer A, Rizopoulos D, Fiocco M, Sonneveld E, de Groot-Kruseman HA, Kuiper RP, Hoogerbrugge P, Horstmann M, Zaliova M, Palmi C, Trka J, Fronkova E, Emerenciano M, do Socorro Pombo-de-Oliveira M, Mlynarski W, Szczepanski T, Nebral K, Attarbaschi A, Venn N, Sutton R, Schwab CJ, Enshaei A, Vora A, Stanulla M, Schrappe M, Cazzaniga G, Conter V, Zimmermann M, Moorman AV, Pieters R, den Boer ML. Boer JM, et al. Among authors: van der veer a. Leukemia. 2016 Jan;30(1):32-8. doi: 10.1038/leu.2015.199. Epub 2015 Jul 23. Leukemia. 2016. PMID: 26202931
Long-term follow-up of children with sickle cell disease diagnosed by newborn screening in the Netherlands: Overview of morbidity and mortality.
Vuong C, Eckhardt CL, Heijboer H, Suijker MH, de Ligt LA, Voigt ALA, Leeflang MMG, Bartels M, Brons P, Hooimeijer L, Rettenbacher E, Smiers FJ, Stein-Wit MA, van der Veer A, Verbaan A, Cnossen MH, Fijnvandraat K. Vuong C, et al. Among authors: van der veer a. Am J Hematol. 2024 Aug;99(8):1606-1609. doi: 10.1002/ajh.27351. Epub 2024 Apr 29. Am J Hematol. 2024. PMID: 38682156 No abstract available.
Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study.
Post DS, van der Veer A, Schijns OEMG, Klinkenberg S, Rijkers K, Wagner GL, van Kranen-Mastenbroek VHJM, Willems PCPH, Verhezen PWM, Beckers EAM, Heubel-Moenen FCJI, Henskens YMC. Post DS, et al. Among authors: van der veer a. PLoS One. 2022 Feb 25;17(2):e0264351. doi: 10.1371/journal.pone.0264351. eCollection 2022. PLoS One. 2022. PMID: 35213601 Free PMC article.
Non-digestible oligosaccharides modulate intestinal immune activation and suppress cow's milk allergic symptoms.
Kerperien J, Jeurink PV, Wehkamp T, van der Veer A, van de Kant HJ, Hofman GA, van Esch EC, Garssen J, Willemsen LE, Knippels LM. Kerperien J, et al. Among authors: van de kant hj, van der veer a, van esch ec. Pediatr Allergy Immunol. 2014 Dec;25(8):747-54. doi: 10.1111/pai.12311. Epub 2014 Dec 18. Pediatr Allergy Immunol. 2014. PMID: 25410019
22 results